Yatin Suneja
Stock Analyst at Guggenheim
(4.64)
# 209
Out of 5,138 analysts
151
Total ratings
60%
Success rate
21.68%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMS Alumis | Maintains: Buy | $18 → $32 | $24.17 | +32.40% | 3 | Jan 7, 2026 | |
| SABS SAB Biotherapeutics | Initiates: Buy | $15 | $4.00 | +275.00% | 1 | Dec 19, 2025 | |
| DBVT DBV Technologies | Maintains: Buy | $35 → $51 | $18.80 | +171.28% | 2 | Dec 17, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $540 → $760 | $297.74 | +155.26% | 4 | Dec 9, 2025 | |
| IFRX InflaRx | Maintains: Buy | $10 → $22 | $1.00 | +2,100.00% | 6 | Nov 10, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $100 | $46.31 | +115.94% | 14 | Nov 5, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $200 → $205 | $174.14 | +17.72% | 9 | Nov 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $815 → $865 | $741.92 | +16.59% | 8 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Upgrades: Buy | $14 | $2.13 | +557.28% | 3 | Oct 27, 2025 | |
| RAPT RAPT Therapeutics | Initiates: Buy | $70 | $32.19 | +117.46% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $32.50 | +84.62% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $116.80 | +28.42% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $128 | $7.94 | +1,512.09% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $16.35 | +22.32% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $1,070 | $813.24 | +31.57% | 13 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $21 | $23.30 | -9.87% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $44.00 | +127.27% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $32.77 | +128.87% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $2.08 | +621.15% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $133.35 | +31.23% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $3.26 | +697.55% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $16.96 | +70.99% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $12 | $14.98 | -19.89% | 4 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.69 | +219.83% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $26.00 | - | 8 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $19.93 | +125.79% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $20.00 | +125.00% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $26.53 | -24.61% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.60 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $33.09 | +96.43% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $25.70 | +250.19% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.91 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $40.74 | +20.27% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $15.84 | +247.22% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $168.57 | +107.63% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.80 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $17.44 | +37.61% | 1 | May 31, 2022 |
Alumis
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $24.17
Upside: +32.40%
SAB Biotherapeutics
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $4.00
Upside: +275.00%
DBV Technologies
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $18.80
Upside: +171.28%
Praxis Precision Medicines
Dec 9, 2025
Maintains: Buy
Price Target: $540 → $760
Current: $297.74
Upside: +155.26%
InflaRx
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $1.00
Upside: +2,100.00%
AnaptysBio
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $46.31
Upside: +115.94%
Axsome Therapeutics
Nov 4, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $174.14
Upside: +17.72%
Regeneron Pharmaceuticals
Oct 29, 2025
Maintains: Buy
Price Target: $815 → $865
Current: $741.92
Upside: +16.59%
Neumora Therapeutics
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $2.13
Upside: +557.28%
RAPT Therapeutics
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $32.19
Upside: +117.46%
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $32.50
Upside: +84.62%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $116.80
Upside: +28.42%
Oct 8, 2025
Maintains: Buy
Price Target: $112 → $128
Current: $7.94
Upside: +1,512.09%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $16.35
Upside: +22.32%
Sep 18, 2025
Reiterates: Buy
Price Target: $1,070
Current: $813.24
Upside: +31.57%
Sep 18, 2025
Maintains: Buy
Price Target: $15 → $21
Current: $23.30
Upside: -9.87%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $44.00
Upside: +127.27%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $32.77
Upside: +128.87%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $2.08
Upside: +621.15%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $133.35
Upside: +31.23%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $3.26
Upside: +697.55%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $16.96
Upside: +70.99%
May 2, 2025
Maintains: Buy
Price Target: $18 → $12
Current: $14.98
Upside: -19.89%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $4.69
Upside: +219.83%
Mar 20, 2025
Reiterates: Buy
Price Target: n/a
Current: $26.00
Upside: -
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $19.93
Upside: +125.79%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $20.00
Upside: +125.00%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $26.53
Upside: -24.61%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.60
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $33.09
Upside: +96.43%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $25.70
Upside: +250.19%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.91
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $40.74
Upside: +20.27%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $15.84
Upside: +247.22%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $168.57
Upside: +107.63%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.80
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $17.44
Upside: +37.61%